David Miyamoto - Publications

University of California, Berkeley, Berkeley, CA 

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Grossman EA, Ward CC, Spradlin JN, Bateman LA, Huffman TR, Miyamoto DK, Kleinman JI, Nomura DK. Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural Products. Cell Chemical Biology. PMID 28919038 DOI: 10.1016/j.chembiol.2017.08.013  0.96
2017 Roberts AM, Miyamoto DK, Huffman TR, Bateman LA, Ives AN, Heslin MJ, Akopian D, Contreras CM, Rape M, Skibola CF, Nomura DK. Chemoproteomic Screening of Covalent Ligands Reveals UBA5 as a Novel Pancreatic Cancer Target. Acs Chemical Biology. PMID 28186401 DOI: 10.1021/acschembio.7b00020  0.96
2016 Louie SM, Grossman EA, Crawford LA, Ding L, Camarda R, Huffman TR, Miyamoto DK, Goga A, Weerapana E, Nomura DK. GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity. Cell Chemical Biology. PMID 27185638 DOI: 10.1016/j.chembiol.2016.03.017  0.68
2014 Hunerdosse DM, Morris PJ, Miyamoto DK, Fisher KJ, Bateman LA, Ghazaleh JR, Zhong S, Nomura DK. Chemical genetics screening reveals KIAA1363 as a cytokine-lowering target. Acs Chemical Biology. 9: 2905-13. PMID 25343321 DOI: 10.1021/cb500717g  0.68
Show low-probability matches.